Understanding Type 1 Diabetes

Type 1 Diabetes is an autoimmune condition where the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Without insulin, glucose cannot enter cells for energy, leading to dangerously high blood sugar levels.

Unlike Type 2 Diabetes, Type 1 is not caused by lifestyle factors. It typically develops in childhood or young adulthood, though it can occur at any age. People with Type 1 Diabetes require lifelong insulin therapy to survive.

Type 1 Diabetes symptoms often develop rapidly, over weeks or even days. The classic symptoms are sometimes called the "4 Ts": Thirst, Toilet (frequent urination), Tiredness, and Thinner (unexplained weight loss).

Diagnosis is confirmed through blood tests including fasting blood glucose, random blood glucose, HbA1c, and antibody tests (GAD, IA-2, ZnT8) that detect the autoimmune process. C-peptide levels help determine how much insulin your body is still producing.

Type 1 Diabetes requires lifelong insulin therapy because the body can no longer produce its own insulin. Modern treatment focuses on mimicking the body's natural insulin patterns as closely as possible.

Treatment options have advanced significantly. Many people now use insulin pumps that deliver continuous small doses of rapid-acting insulin, combined with continuous glucose monitors (CGM) that track blood sugar levels in real-time.

Monitoring blood glucose levels is essential for managing Type 1 Diabetes safely and effectively. Modern technology has transformed how people can track their levels.

Continuous Glucose Monitors (CGM) use a small sensor under the skin to measure glucose levels every few minutes. They provide trend arrows, alerts for highs and lows, and detailed data to help optimise insulin dosing.

The focus has shifted from just HbA1c to "Time in Range" — the percentage of time your glucose stays within the target range. Studies show that more time in range leads to fewer complications and better quality of life.

LADA is sometimes called "Type 1.5 Diabetes." It's an autoimmune form of diabetes that develops more slowly than typical Type 1, usually in adults over 30. Because symptoms develop gradually, LADA is often initially misdiagnosed as Type 2 Diabetes.

People with LADA may initially respond to oral diabetes medications, but will eventually require insulin — usually within 5 years of diagnosis. Antibody testing can confirm LADA.

Long-term high blood glucose levels can damage blood vessels and nerves, leading to complications. The good news: maintaining good glucose control significantly reduces the risk of these complications.